Preliminary trials for production of trivalent inactivated oil vaccine against newcastle,infectious bronchitis and egg drop syndrome diseases [electronic resource].

By: Contributor(s): Language: English Summary language: Arabic Description: p.45-54Other title:
  • محاولات مبدئية لتحضير لقاح ثلاثى مثبط زيتي ضد أمراض النيوكاسل والألتهاب الشعبي المعدي وتدني البيض فى الدجاج [Added title page title]
Uniform titles:
  • Journal of Veterinary Medical Researches, 2001 v.3 (2) [electronic resource].
Subject(s): Online resources: In: Journal of Veterinary Medical Researches 2001.v.3(2)Summary: Newcastle disease virus (NDV}, egg drop syndrome (EDS) and infectious bronchitis (IBV) combined trivalent and monovalent oil adjuvant uaccines were prepared and tested for safety and immunogenicity in 4 week-old commercial chickens. The chickens vaccinated with a dose of O.5ml developed satisfactory levels of antibodies to ND. EDS and IB viruses. The results showed that no significant differences in antibody titres be- tween the respective groups up to 8 week observation period So, the trivalent vaccine was safe and immunogenic against NDV, EDSV and IBV in one dose.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Includes references.

Newcastle disease virus (NDV}, egg drop syndrome (EDS) and infectious bronchitis (IBV) combined trivalent and monovalent oil adjuvant uaccines were prepared and tested for safety and immunogenicity in 4 week-old commercial chickens. The chickens vaccinated with a dose of O.5ml developed satisfactory levels of antibodies to ND. EDS and IB viruses. The results showed that no significant differences in antibody titres be- tween the respective groups up to 8 week observation period So, the trivalent vaccine was safe and immunogenic against NDV, EDSV and IBV in one dose.

Summary in Arabic.

1

There are no comments on this title.

to post a comment.

Home | About ENAL | Collections | Services | Activities | Calendar | Contact us

7 Nadi El Sayed St., Gizah, Egypt | Phone: +02-33351313 | Fax: 202 33351302 | Email: enalegypt@gmail.com